---
category: listing
circular_id: e08371d04524c64b
date: '2025-12-29'
description: Gujarat Kidney And Super Speciality Limited equity shares to be listed
  on NSE Capital Market segment with effect from December 30, 2025.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML72037.zip
impact: low
impact_ranking: low
importance_ranking: medium
justification: Standard IPO listing notification with medium importance for investors
  interested in healthcare sector stocks, low overall market impact as it affects
  only new listing participants
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML72037.zip
processing:
  attempts: 1
  content_hash: 4bc7a11f0b47880f
  processed_at: '2025-12-29T12:49:54.439580'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-29T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML72037.zip
severity: low
source: nse
stocks:
- GKSL
tags:
- ipo
- listing
- equity-shares
- new-listing
- capital-market
- gksl
title: Listing of Equity Shares of Gujarat Kidney And Super Speciality Limited (IPO)
---

## Summary

National Stock Exchange of India has notified the listing of equity shares of Gujarat Kidney And Super Speciality Limited (Symbol: GKSL) on the Capital Market segment effective December 30, 2025. The company issued 78,843,250 equity shares of face value Rs. 2/- each at an issue price of Rs. 114/- per share. The security will be part of the pre-open session for IPO category as per SEBI circular guidelines.

## Key Points

- **Symbol**: GKSL
- **ISIN**: INE0V0W01025
- **Series**: EQ
- **Face Value**: Rs. 2/- per share
- **Issue Price**: Rs. 114/- per share
- **Total Shares Issued**: 78,843,250 equity shares
- **Market Lot**: 1 share
- **Pari Passu**: Yes
- **Pre-open Session**: Applicable for IPO category
- **Registrar**: MUFG Intime India Private Limited (formerly Link Intime India Private Limited)

## Regulatory Changes

No regulatory changes introduced. This circular is a standard listing notification under Regulation 3.1.1 and 2.5.5 of NSE Capital Market Trading Regulations Part A.

## Compliance Requirements

- Members must identify the security by its designated code (GKSL) for trading purposes
- Trading shall be conducted in the specified market lot size of 1 share
- The security will participate in pre-open session as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012

## Important Dates

- **Circular Date**: December 29, 2025
- **Effective Date**: December 30, 2025
- **Financial Year**: April 2025 - March 2026
- **Lock-in Periods**: Various tranches with lock-in dates ranging from January 24, 2026 to January 2, 2029 (detailed in Annexure I)
  - 13,226,880 shares are free from lock-in
  - Multiple tranches locked until July 2, 2026, January 24-25, 2026, March 25, 2026, January 2, 2027, and January 2, 2029

## Impact Assessment

**Market Impact**: Low - This is a routine IPO listing in the healthcare/hospital sector. The company operates kidney and super-specialty hospital services based in Vadodara, Gujarat.

**Investor Impact**: Medium for IPO participants and healthcare sector investors. The listing provides liquidity to IPO allottees and enables secondary market trading.

**Operational Impact**: Standard listing procedures apply. Trading members can commence trading from December 30, 2025 in the specified lot size.

**Company Details**:
- **Registered Office**: Plot No. 1, City Survey No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara â€“ 390020, Gujarat
- **Contact**: +91 265 298 4800
- **Website**: www.gujaratsuperspecialityhospital.com
- **Company Secretary**: Ms. Niki Paresh Tiwari